Change of Adviser and Update on Directors’ Disclosures

http://novacyt.com/wp-content/uploads/2019/05/Novacyt-Change-of-Adviser-03.05.19.pdf

Paris, France and Camberley, UK – 3 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the appointment of SP Angel Corporate Finance LLP as its Nominated Adviser and joint broker with immediate effect.